Nick Finer - Concepedia

Author

Nick Finer

Also Known As

- Nick Finer, Christian Torp‐Pedersen, FINER, N, FINER, N., Finer, Finer, N, Finer, N., Finer, Nicholas, G. S. Frost, Gaal Belgium

362

Publications

13.9K

Citations

H-Index

123

Concepts

All Affiliations

University College London The University of Sydney London School of Hygiene & Tropical Medicine University of Alberta Royal Alexandra Hospital

About

Nick Finer is an author at University College London specializing in medicine, obesity, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	43	4.5K
2	Health Sciences	15	20	1.6K
3	Public Health	12	14	935
4	Social Sciences	1	1	30
5	Anesthesia	1	1	20

Nick Finer

Publications

7.7K

Citations

H-Index

Page 1

	Year	Citations
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects W. P. T. James, Ian D. Caterson, Walmir Coutinho, New England Journal of Medicine	2010	924
Effect of sibutramine on weight maintenance after weight loss: a randomised trial W. P. T. James, Arne Astrup, Nick Finer, The Lancet ObesityNutritionWeight LossWeight MaintenanceRandomised Trial	2000	817
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study André Scheen, Nick Finer, Priscilla Hollander, The Lancet ObesityMetabolic SyndromeDiabetes ManagementInsulin ManagementDiabetes	2006	735
Management of Obesity in Adults: European Clinical Practice Guidelines Constantine Tsigos, Vojtěch Hainer, Arnaud Basdevant, Obesity Facts Bariatric SurgeryWeight ManagementObesity TreatmentObesity PreventionObesity	2008	439
Obesity surgery: Evidence-based guidelines of the European Association for Endoscopic Surgery (EAES) Stefan Sauerland, Luigi Angrisani, M. Belachew, Surgical Endoscopy ObesityBariatric SurgeryEvidence-based GuidelinesGastroenterologyObesity Management	2004	419
One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor Nick Finer, W. P. T. James, PG Kopelman, International Journal of Obesity ObesityMetabolic SyndromeNutritionBariatric SurgeryMedicine	2000	319
Inter-disciplinary European guidelines on surgery of severe obesity Martin Fried, Vojtěch Hainer, A Basdevant, International Journal of Obesity ObesityBariatric SurgeryBody CompositionInter-disciplinary European GuidelinesPatient Safety	2007	297
Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double‐blind, placebo‐controlled study Nick Finer, S R Bloom, Gary Frost, Diabetes Obesity and Metabolism	2000	169
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension Jens Jordan, Volkan Yumuk, Markus P. Schlaich, Journal of Hypertension HypertensionCardiometabolic RiskJoint StatementBlood PressureObesity Prevention	2012	151
Tamoxifen-Induced Anorexia Is Associated With Fatty Acid Synthase Inhibition in the Ventromedial Nucleus of the Hypothalamus and Accumulation of Malonyl-CoA Miguel López, Christopher J. Lelliott, Sulay Tovar, Diabetes Fatty Acid SynthaseObesityMetabolic SyndromeBody CompositionHypothalamic Peptide	2006	150

Page 1